13 completed, 2 not yet recruiting, 1 active not recruiting, 1 recruiting. 3 Not applicable, 3 Phase 2, 2 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 2, Not yet recruiting 1 |
| Phase 2 | 3 | Completed 3 |
| Phase 3 | 2 | Completed 2 |
| Phase 4 | 1 | Not yet recruiting 1 |
Follow Ovulation: new trials by email Literature Review of Ovulation trials Research Report on Ovulation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| FemiClock: Non-invasive Tools Development (Salivary and Hair Progesterone) for Ovulation Detection in Heathy Women With Regular Menstrual Cycles Without Contraception. Diagnostic Test: Non-invasive ovulation biomarker assessment - Smartwatch, Diagnostic Test: Non-invasive ovulation biomarker assessment - Questionnaires, Hormonal blood assessment - Ovulation, Female Fertility | Not applicable | Not yet recruiting | University Hospital, Strasbourg, France | 30 | 2026-09-01 | 2026-07-07 |
| Exogenous Progesterone as Ovulation Trigger Vaginal micronized progesterone - Ovulation, Ovarian Function | Phase 4 | Not yet recruiting | Instituto Valenciano de Infertilidade de Lisboa | 10 | 2026-07-01 | 2026-06-04 |
| Smartphone vs Manual Interpretation of Biomarkers for Ovulation and Luteal Phase Detection (SMOM Study) Premom App-Assisted Fertility Tracking - Fertility, Mobile Applications | Active not recruiting | Bruyère Health Research Institute. | 30 | 2026-01-15 | 2026-07-27 | |
| Menstrual Cycle Study Menstruation, Ovulation | Completed | Fitbit LLC | 143 | 2023-07-25 | 2024-12-20 | |
| Sensor Technology Assessments of Reproductive Target Study Menstrual Cycle, Ovulation | Completed | Ouraring Inc. | 119 | 2022-06-15 | 2024-10-15 | |
| Evaluation of D-chiro-inositol Treatments D-chiro-inositol - Inositol, Testosterone | Not applicable | Completed | Lo.Li.Pharma s.r.l | 10 | 2022-06-04 | 2022-09-19 |
| Impact of Menstrual Phase on Oral Glucose Sensitivity Urinary Estrogen Level - Ovulation, Menstruation | Completed | Rutgers, The State University of New Jersey | 22 | 2021-11-03 | 2025-01-30 | |
| Heart Rate Variability During the Menstrual Cycle Ovulation | Completed | SPD Development Company Limited | 28 | 2020-06-01 | 2021-08-06 | |
| Apple Women's Health Study Menstrual Cycle, Ovulation | Recruiting | Apple Inc. | 500000 | 2019-11-14 | 2024-07-03 | |
| Investigation of Heart Rate Variability During the Menstrual Cycle Ovulation | Completed | SPD Development Company Limited | 12 | 2019-07-19 | 2020-02-20 | |
| The Effect of Cinnamon on Ovulation Induction in Women With Polycystic Ovary Syndrome Cinnamon Cap 500 MG, Placebo - Polycystic Ovary Syndrome, Ovulation | Phase 3 | Completed | King Abdulaziz University | 33 | 2018-09-20 | 2020-03-03 |
| Can Ibuprofen Delay Ovulation in Natural Cycle-IVF? Ibuprofen - Ovulation, Ovulation Inhibition | Phase 2 | Completed | Insel Gruppe AG, University Hospital Bern | 51 | 2016-01-01 | 2024-11-19 |
| Ovulation Incidence in Oral Contraceptive Users Ethinyl Estradiol, Norethindrone acetate, ferrous fumarate, Norethindrone - Contraception, Ovulation | Phase 3 | Completed | University of Southern California | 58 | 2014-08-01 | 2025-12-26 |
| Accuracy of SPD Persona LH Assay When Compared to Ultrasound Observed Ovulation and Other Indices of Ovulation Ovulation | Completed | SPD Development Company Limited | 51 | 2013-02-01 | 2014-12-02 | |
| The Effect of a Non-hormonal Cox-2 Inhibitor (Celebrex) on Ovulation Celebrex, Placebo - Ovulation, Luteal Development | Not applicable | Completed | Oregon Health and Science University | 20 | 2009-09-01 | 2019-06-18 |
| A Phase 2, Dose-finding, Cross-over Study to Evaluate the Effect of a NES/E2 Transdermal Gel Delivery on Ovulation Suppression in Normal Ovulating Women NES/E2 gel - Ovulation | Phase 2 | Completed | Population Council | 18 | 2008-11-01 | 2015-04-17 |
| Study Evaluating Effects of Levonorgestrel and Ethinyl Estradiol on Ovulation Levonorgestrel, Ethinyl Estradiol - Ovulation | Phase 2 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 60 | 2002-12-01 | 2006-05-19 |
Polycystic Ovary Syndrome (2) · Arachnodactyly (1) · Hypersensitivity (1) · Infertility (1) · Insulin Resistance (1)
Adnexal Diseases (2) · Cysts (2) · Endocrine System Diseases (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genital Diseases (2) · Genital Diseases, Female (2) · Gonadal Disorders (2) · Neoplasms (2) · Ovarian Cysts (2) · Ovarian Diseases (2) · Urogenital Diseases (2) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Glucose Metabolism Disorders (1)
Ethinyl Estradiol (2) · Celecoxib (1) · Ibuprofen (1) · Levonorgestrel (1) · Norethindrone (1) · Norethindrone Acetate (1) · Progesterone (1) · ferrous fumarate (1) · norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination (1)
SPD Development Company Limited (3) · Apple Inc. (1) · Bruyère Health Research Institute. (1) · Fitbit LLC (1) · Insel Gruppe AG, University Hospital Bern (1) · Instituto Valenciano de Infertilidade de Lisboa (1) · King Abdulaziz University (1) · Lo.Li.Pharma s.r.l (1) · Oregon Health and Science University (1) · Ouraring Inc. (1) · Population Council (1) · Rutgers, The State University of New Jersey (1) · University Hospital, Strasbourg, France (1) · University of Southern California (1) · Wyeth is now a wholly owned subsidiary of Pfizer (1)
United States (7) · United Kingdom (2) · Canada (1) · Chile (1) · Dominican Republic (1) · Germany (1) · Italy (1) · Portugal (1) · Saudi Arabia (1) · Switzerland (1)
Sarah Johnson (2) · Alison Edelman, MD, MPH (1) · Ana Raquel Neves (1) · Brent A Coull, PhD (1) · Brian T Nguyen, MD, MSc (1) · Christian Gnoth, Dr (1) · Daniel Johnson, DO (1) · Eleni Jaswa, M.D., M.Sc. (1) · Michael von Wolff, Prof. Dr. (1) · Michelle A Williams, SM, ScD (1) · Paul A Breslin, PhD (1) · Russ B Hauser, MD, MPH, ScD (1) · Shruthi Mahalingaiah, MD, MS (1)
PMID 19698816, PMID 22902348, PMID 25720077, PMID 26032952, PMID 26384163, PMID 36414993, PMID 40073916
R21DC020365 (1)